← Back to Search

Dietary Oxalate Intake for Kidney Stone Prevention

N/A
Waitlist Available
Led By Tanecia Mitchell, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 to 70 years
Mentally competent adults who are able to read and comprehend the consent form, written in English
Must not have
Any medical disorder that could influence absorption or excretion of oxalate
Mentally incompetent adults who are unable to read or comprehend the consent form, written in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 hours - 5 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how well the body processes oxalate after eating, which is found in some leafy greens and other foods.

Who is the study for?
This trial is for mentally competent adults aged 18-70, with a BMI of 19-27, who don't use tobacco or vigorous exercise during the study. They must understand English consent forms and have normal blood tests. It's not for pregnant individuals, those on medications/supplements, with medical problems or history of kidney stones.
What is being tested?
The study is testing how different drinks (kale smoothie, spinach smoothie, sodium oxalate drink) affect immune cell function in healthy people by looking at mitochondrial function in white blood cells and platelets after consuming dietary oxalate.
What are the potential side effects?
Since this trial involves dietary intake rather than medication, side effects may be minimal but could include digestive discomfort from the smoothies or changes in bowel habits due to high oxalate levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old.
Select...
I can read and understand English and am mentally capable of making my own decisions.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a condition that affects how my body absorbs or gets rid of oxalate.
Select...
I am able to understand and consent to the study on my own.
Select...
I have had kidney stones in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 hours - 5 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 hours - 5 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in monocyte cellular energetics after 5 hours

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

8Treatment groups
Experimental Treatment
Group I: 5d Diet+Spinach Smoothie+BreakfastExperimental Treatment2 Interventions
5 days of prepared meals with fasting on the final day. On final day, participants will return to the study site and drink a prepared blended spinach smoothie and be provided a breakfast meal.
Group II: 3d Diet+V Spinach Smoothie+BreakfastExperimental Treatment2 Interventions
3 days of prepared meals with fasting on the final day. On final day, participants will return to the study site and drink a prepared blended spinach smoothie with varying amounts of spinach and be provided a breakfast meal.
Group III: 3d Diet+Spinach Smoothie+Breakfast w/ 24 Hr UrineExperimental Treatment2 Interventions
3 days of prepared meals with fasting on the final day. On final day, participants will return to the study site and drink a blended spinach smoothie and be provided a breakfast meal.
Group IV: 3d Diet+Spinach Smoothie+BreakfastExperimental Treatment2 Interventions
3 days of prepared meals with fasting on the final day. On final day, participants will return to study site and drink a prepared blended spinach smoothie and be provided a breakfast meal.
Group V: 3d Diet+Sodium Oxalate Drink+BreakfastExperimental Treatment2 Interventions
3 days of prepared meals with fasting on the final day. On final day, participants will return to the study site and drink a prepared sodium oxalate drink and be provided a breakfast meal.
Group VI: 3d Diet+Kale Smoothie+BreakfastExperimental Treatment2 Interventions
3 days of prepared meals with fasting on the final day. On the final day, participants will return to the study site and drink a prepared kale smoothie and be provided a breakfast meal.
Group VII: 3d Diet+BreakfastExperimental Treatment1 Intervention
3 days of prepared meals with fasting on the final day. On final day, participants will return to the study site and be provided a breakfast meal.
Group VIII: 3d Diet+Blended Smoothie+BreakfastExperimental Treatment2 Interventions
3 days of prepared meals with fasting on the final day. On final day, participants will return to the study site and drink a prepared blended smoothie and be provided a breakfast meal.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Breakfast
2015
Completed Phase 3
~310

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,291 Total Patients Enrolled
13 Trials studying Kidney Stones
659 Patients Enrolled for Kidney Stones
Tanecia Mitchell, PhDPrincipal Investigator - University of Alabama at Birmingham
University of Alabama at Birmingham
3 Previous Clinical Trials
196 Total Patients Enrolled
3 Trials studying Kidney Stones
196 Patients Enrolled for Kidney Stones

Media Library

Dietary Oxalate Clinical Trial Eligibility Overview. Trial Name: NCT03877276 — N/A
Kidney Stones Research Study Groups: 3d Diet+Sodium Oxalate Drink+Breakfast, 3d Diet+Kale Smoothie+Breakfast, 3d Diet+V Spinach Smoothie+Breakfast, 3d Diet+Blended Smoothie+Breakfast, 3d Diet+Spinach Smoothie+Breakfast w/ 24 Hr Urine, 5d Diet+Spinach Smoothie+Breakfast, 3d Diet+Breakfast, 3d Diet+Spinach Smoothie+Breakfast
Kidney Stones Clinical Trial 2023: Dietary Oxalate Highlights & Side Effects. Trial Name: NCT03877276 — N/A
Dietary Oxalate 2023 Treatment Timeline for Medical Study. Trial Name: NCT03877276 — N/A
~4 spots leftby Jun 2025